Established in 2008, Neptune Bioressources and Technologies Inc.'s subsidiaries take advantage of Neptune’s intellectual property, clinical data and long-term industry expertise to develop a pharmaceutical product portfolio based on proprietary, purified concentrated omega-3 phospholipids within the over-the-counter (OTC), medical food (MF) and prescription drug (Rx) markets (Rx).
Acasti Pharma focuses on bridging the treatment gap for chronic cardiovascular conditions. The company advances a range of bioactive proprietary omega-3 phospholipid ingredients through pharmaceuticals including prescription medical foods, over-the-counter products and prescription drugs.
NeuroBioPharm’s mission is to research and develop proprietary active pharmaceutical ingredients that target neurological conditions. The conditions range from brain development to various neurodegenerative diseases, including attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease and cognitive decline. NeuroBioPharm seeks corporate partnerships, strategic alliances and research collaborations to add value to its research and development, financial and/or commercialization capabilities.